Financials
- Fiscal year
- 2024
- Total assets
- €77,784
- Profit
- €9,391
- Solvency
- 41.5%
Total assets▲ 190%
Net result
20212024
PANDA PLUS
ActiveSummary
The computed 12-month bankruptcy probability of PANDA PLUS is 4.1% (elevated). The 2024 annual accounts show equity of €32,313 and a net result of €9,391. Equity is growing by ~6.4% per year across the filed fiscal years. Its solvency ranks better than 58% of 26069 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730Retail trade NACE 47622
1 site
Size
€77,784total assets 2024
- Equity
- €32,313
- Profit
- €9,391
Turnover not published (abridged schema)
Structure
Accounts 67 d overdue0 of 2 deeds read
Why 50- Figures for FY 2024 (filed 23-10-2025)- 1 financial year not filed after the legal deadline; latest accounts 84 days late; 1 of the last 3 late- Founded in 2021+ Liquidity: current ratio 1.28, cash €29,861Show the evidence
Checked score
Score 2024
50
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 73% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2023
Strong
Solvency
67-33
equity 41.5% of total assets
Liquidity
68-29
short-term debt 58.5% · cash 38.4%
Profitability
84+84
return on assets 12.1%
Bankruptcy probability, 12 months
4.1%
Elevated
0%0.5%1.5%4%10%≥ 25%
About 4 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.4%
12-2024: 0.3%▼ -1.4% vs 11-2024
01-2025: 0.3%● 0.0% vs 12-2024
02-2025: 0.3%▼ -0.9% vs 01-2025lowest value
03-2025: 0.3%▲ +1.5% vs 02-2025
04-2025: 0.4%▲ +4.9% vs 03-2025
05-2025: 0.4%▲ +11.8% vs 04-2025
06-2025: 0.4%▲ +2.9% vs 05-2025
07-2025: 0.5%▲ +10.0% vs 06-2025
08-2025: 0.8%▲ +67.3% vs 07-2025
09-2025: 0.9%▲ +20.7% vs 08-2025
10-2025: 1.7%▲ +77.3% vs 09-2025
11-2025: 1.8%▲ +7.6% vs 10-2025
12-2025: 1.8%● 0.0% vs 11-2025
01-2026: 1.7%▼ -2.1% vs 12-2025
02-2026: 1.7%▲ +0.5% vs 01-2026
03-2026: 1.7%▼ -5.2% vs 02-2026
04-2026: 1.7%▼ -0.1% vs 03-2026
05-2026: 1.7%▼ -0.4% vs 04-2026
06-2026: 1.6%▼ -1.8% vs 05-2026
07-2026: 1.6%▲ +1.0% vs 06-2026
08-2026: 2.5%▲ +53.3% vs 07-2026
09-2026: 2.8%▲ +11.1% vs 08-2026
10-2026: 4.1%▲ +48.5% vs 09-2026highest value
- Figures for FY 2024 (filed 23-10-2025) raises the probability
- 1 financial year not filed after the legal deadline; latest accounts 84 days late; 1 of the last 3 late raises the probability
- Founded in 2021 raises the probability for this profile
- Liquidity: current ratio 1.28, cash €29,861 lowers the probability
Credit up to €1,500 at 30 days only on tighter terms
Liquidity tight (current ratio 1.28 against 6.92 in 2023; short-term debt: 58.5% and cash: 38.4% of total assets), and 58.5% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 56%, liquidity 74%, profitability 78%, growth against the median 84%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 05-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 23-10-2025, 84 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 4 filingsDeviation from the deadline
2025
not confirmed
2024
84 d late
2023
1 d late
2022
7 d early
2021
30 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 4 accounts on average 27 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2024 · micro…
- Back to profitnet €9,391
- Annual accounts filedfiscal year 2023 · micro…
Key points
By topic
Timeline
- Events
- 8
- Since
- 2022
- 23-10-2025Annual accounts filed
- 31-12-2024Back to profit
- 01-08-2024Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 26-02-2021
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.